What Researchers Did
Researchers conducted a systematic review and meta-analysis of 20 randomized clinical trials to evaluate the effectiveness of hyperbaric oxygen therapy for diabetic foot ulcers.
What They Found
They found that hyperbaric oxygen therapy significantly increased the healing rate of diabetic foot ulcers (relative risk 1.901) and shortened healing time by an average of 19.36 days. Furthermore, HBOT reduced the incidence of major amputation by nearly half (relative risk 0.518).
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers may benefit from hyperbaric oxygen therapy as a treatment option. This therapy could potentially improve wound healing and reduce the risk of major amputations, leading to better patient outcomes.
Canadian Relevance
This study has no direct Canadian connection, as it was not conducted in Canada nor focused on Canadian populations.
Study Limitations
The authors noted that larger and more well-designed randomized controlled trials are needed to further verify these conclusions.